BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26607405)

  • 1. Blood-brain barrier damage in vascular dementia.
    Ueno M; Chiba Y; Matsumoto K; Murakami R; Fujihara R; Kawauchi M; Miyanaka H; Nakagawa T
    Neuropathology; 2016 Apr; 36(2):115-24. PubMed ID: 26607405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elucidation of mechanism of blood-brain barrier damage for prevention and treatment of vascular dementia].
    Ueno M
    Rinsho Shinkeigaku; 2017 Mar; 57(3):95-109. PubMed ID: 28228623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of matrix metalloproteinase-13 is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
    Ueno M; Wu B; Nishiyama A; Huang CL; Hosomi N; Kusaka T; Nakagawa T; Onodera M; Kido M; Sakamoto H
    Hypertens Res; 2009 May; 32(5):332-8. PubMed ID: 19300451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier and blood-cerebrospinal fluid barrier in normal and pathological conditions.
    Ueno M; Chiba Y; Murakami R; Matsumoto K; Kawauchi M; Fujihara R
    Brain Tumor Pathol; 2016 Apr; 33(2):89-96. PubMed ID: 26920424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of osteopontin is increased in vessels with blood-brain barrier impairment.
    Iwanaga Y; Ueno M; Ueki M; Huang CL; Tomita S; Okamoto Y; Ogawa T; Ueda N; Maekawa N; Sakamoto H
    Neuropathol Appl Neurobiol; 2008 Apr; 34(2):145-54. PubMed ID: 17973907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of N-Acetylcysteine on cerebral amyloid-β plaques and kidney damage in spontaneously hypertensive stroke-prone rats.
    Bueche CZ; Garz C; Stanaszek L; Niklass S; Kropf S; Bittner D; Härtig W; Reymann KG; Heinze HJ; Carare RO; Schreiber S
    J Alzheimers Dis; 2014; 42 Suppl 3():S305-13. PubMed ID: 24898644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of CD36 in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
    Ueno M; Nakagawa T; Nagai Y; Nishi N; Kusaka T; Kanenishi K; Onodera M; Hosomi N; Huang C; Yokomise H; Tomimoto H; Sakamoto H
    Neuropathol Appl Neurobiol; 2011 Dec; 37(7):727-37. PubMed ID: 21418266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbance of Intracerebral Fluid Clearance and Blood-Brain Barrier in Vascular Cognitive Impairment.
    Ueno M; Chiba Y; Murakami R; Matsumoto K; Fujihara R; Uemura N; Yanase K; Kamada M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats.
    Ueno M; Sakamoto H; Tomimoto H; Akiguchi I; Onodera M; Huang CL; Kanenishi K
    Acta Neuropathol; 2004 Jun; 107(6):532-8. PubMed ID: 15042385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between hypertension and cerebral hypoperfusion in the development of cognitive dysfunction and white matter pathology in rats.
    Choi JY; Cui Y; Kim BG
    Neuroscience; 2015 Sep; 303():115-25. PubMed ID: 26143013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice.
    del Valle J; Duran-Vilaregut J; Manich G; Pallàs M; Camins A; Vilaplana J; Pelegrí C
    Neurodegener Dis; 2011; 8(6):421-9. PubMed ID: 21411981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
    Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
    J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of P-glycoprotein is increased in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.
    Ueno M; Nakagawa T; Huang CL; Ueki M; Kusaka T; Hosomi N; Kanenishi K; Onodera M; Wu B; Sakamoto H
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):147-55. PubMed ID: 19284476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aquaporins 1 and 4 in the brain of spontaneously hypertensive rats.
    Tomassoni D; Bramanti V; Amenta F
    Brain Res; 2010 Apr; 1325():155-63. PubMed ID: 20156423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of autophagy dysfunction as a potential mechanism for environmental enrichment to protect blood-brain barrier in rats with vascular cognitive impairment.
    Xu L; Qu C; Qu C; Shen J; Song H; Li Y; Li T; Zheng J; Zhang J
    Neurosci Lett; 2020 Nov; 739():135437. PubMed ID: 33132180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporal evolution of blood brain barrier damage and tissue infarction within the first 3h after ischemia onset.
    Jin X; Liu J; Yang Y; Liu KJ; Yang Y; Liu W
    Neurobiol Dis; 2012 Dec; 48(3):309-16. PubMed ID: 22813865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier impairment in dementia: current and future in vivo assessments.
    van de Haar HJ; Burgmans S; Hofman PA; Verhey FR; Jansen JF; Backes WH
    Neurosci Biobehav Rev; 2015 Feb; 49():71-81. PubMed ID: 25524876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia.
    Krueger M; Bechmann I; Immig K; Reichenbach A; Härtig W; Michalski D
    J Cereb Blood Flow Metab; 2015 Feb; 35(2):292-303. PubMed ID: 25425076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency.
    Chen X; Chen L; Lin G; Wang Z; Kodali MC; Li M; Chen H; Lebovitz SG; Ortyl TC; Li L; Ismael S; Singh P; Malik KU; Ishrat T; Zhou FM; Zheng W; Liao FF
    Mol Psychiatry; 2022 Nov; 27(11):4754-4769. PubMed ID: 35948662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.